A single-nucleotide polymorphism in TLR4 is linked with the risk of HIV-1 infection

References

• Cohen DE, Walker BD. Human immunodeficiency virus pathogenesis and prospects for immune control in patients with established infection. Clin Infect Dis. 2001;32:1756–1768.
   PubMed Web of Science ®Google Scholar
• Goh WC, Markee J, Akridge RE, et al. Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects. J Infect Dis. 1999;179:548–557.
   PubMed Web of Science ®Google Scholar
• Plummer FA, Ball TB, Kimani J, et al. Resistance to HIV-1 infection among highly exposed sex workers in Nairobi: what mediates protection and why does it develop? Immunol Lett. 1999;66:27–34.
   PubMed Web of Science ®Google Scholar
• Mazzoli S, Trabattoni D, Lo Caputo S, et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med. 1997;3:1250–1257.
   PubMed Web of Science ®Google Scholar
• Detels R, Liu Z, Hennessey K, et al. Resistance to HIV-1 infection. Multicenter AIDS cohort study. J Acquir Immune Defic Syndr. 1994;7(12):1263–1269.
   PubMed Web of Science ®Google Scholar
• Phair J, Jacobson L, Detels R, et al. Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS cohort study. J Acquir Immune Defic Syndr. 1992;5(5):490–496.
   PubMed Web of Science ®Google Scholar
• Sodora DL, Silvestri G. Immune activation and AIDS pathogenesis. AIDS. 2008;22:439–446.
   PubMed Web of Science ®Google Scholar
• Noursadeghi M, Katz DR, Miller RF. HIV-1 infection of mononuclear phagocytic cells: the case for bacterial innate immune deficiency in AIDS. Lancet Infect Dis. 2006;6:794–804.
   PubMed Web of Science ®Google Scholar
• Barton GM, Medzhitov R. Toll-like receptor signaling pathways. Science. 2003;300:1524–1525.
   PubMed Web of Science ®Google Scholar
• Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science. 2010;327(5963):291–295.
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11(5):373–384.
   PubMed Web of Science ®Google Scholar
• Misch EA, Hawn TR. Toll-like receptor polymorphisms and susceptibility to human disease. Clin Sci (Lond). 2008;114(5):347–360.
   PubMed Web of Science ®Google Scholar
• Ferwerda B, McCall MB, Verheijen K, et al. Functional consequences of toll-like receptor 4 polymorphisms. Mol Med. 2008;14(5–6):346–352.
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. TLR signaling. Cell Death Differ. 2006;13(5):816–825.
   PubMed Web of Science ®Google Scholar
• Vajpayee M, Kaushik S, Sreenivas V, et al. CDC staging based on absolute CD4 count and CD4 percentage in an HIV-1 infected Indian population: treatment implication. Clin Exp Immunol. 2005;141:485.
   PubMed Web of Science ®Google Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
   PubMed Web of Science ®Google Scholar
• Verma A, Prasad KN, Gupta RK, et al. Toll-like receptor 4 polymorphism and its association with symptomatic neurocysticercosis. J Infect Dis. 2010;202:1219.
   PubMed Web of Science ®Google Scholar
• Schröder NW, Schumann RR. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis. 2005;5:156–164.
   PubMed Web of Science ®Google Scholar
• Turvey SE, Hawn TR. Towards subtlety: understanding the role of Toll-like receptor signaling in susceptibility to human infections. Clin Immunol. 2006;120:1–9.
   PubMed Web of Science ®Google Scholar
• Nyati KK, Prasad KN, Verma A, et al. Association of TLR4 Asp299Gly and Thr399Ile polymorphisms with Guillain-Barré syndrome in Northern Indian population. J Neuroimmunol. 2010;218(1–2):116–119.
   PubMed Web of Science ®Google Scholar
• Sinha S, Singh J, Jindal SK, et al. Role of TLR4 C>1196T (Thr399Ile) and TLR4 A>896G (Asp299Gly) polymorphisms in a North Indian population with asthma: a case-control study. Int J Immunogenet. 2014;41(6):463–471.
   PubMed Web of Science ®Google Scholar
• Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365–1371.
   PubMed Web of Science ®Google Scholar
• Chang JJ, Altfeld M. TLR-mediated immune activation in HIV. Blood. 2009;113:269–270.
   PubMed Web of Science ®Google Scholar
• Ferwerda B, Alonso S, Giamarellos-Bourboulis EJ, et al. TLR4 Polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci USA. 2007;104:16645–16650.
   PubMed Web of Science ®Google Scholar
• Figueroa L, Xiong Y, Song C, et al. Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF. J Immunol. 2012;188:4506–4515.
   PubMed Web of Science ®Google Scholar
• Pine SO, McElrath MJ, Bochud PY. Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals. AIDS. 2009;23(18):2387–2395.
   PubMed Web of Science ®Google Scholar
• Soriano-Sarabia N, Vallejo A, Ramírez-Lorca R, et al. Influence of the Toll-like receptor 9 1635A/G polymorphism on the CD4 count, HIV viral load, and clinical progression. J Acquir Immune Defic Syndr. 2008;49(2):128–135.
   PubMed Web of Science ®Google Scholar
• Said EA, Al-Yafei F, Zadjali F, et al. Frequency of TLR4 (1063A/G and 1363C/T) polymorphisms in healthy and HIV-infected Omani individuals and their relationship to viral load and T cell count. Genet Mol Res. 2016;15:2.
   Web of Science ®Google Scholar
• Ferwerda B, Kibiki GS, Netea MG, et al. The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania. Aids. 2007;21:1375–1377.
   PubMed Web of Science ®Google Scholar
• Papadopoulos AI, Ferwerda B, Antoniadou A, et al. Association of toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms with increased infection risk in patients with advanced HIV-1 infection. Clin Infect Dis. 2010;51(2):242–247.
   PubMed Web of Science ®Google Scholar
• Redd AD, Dabitao D, Bream JH, et al. Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa. Proc Natl Acad Sci USA. 2009;106:6718–6723.
   PubMed Web of Science ®Google Scholar